Diabetes Clinical Trial
— DKAOfficial title:
Integration of a Computer‐Based Simulation of DKA Management Into Medical Education: A 2 by 2 Factorial Cluster Randomized Controlled Trial
| Verified date | June 2016 |
| Source | St. Michael's Hospital, Toronto |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Canada: Institutional Review Board |
| Study type | Interventional |
A 2-by-2 factorial cluster randomized controlled trial was performed to: 1) Compare the effects of supervised (coached) versus unsupervised (no coach) administration of the DKA simulator on trainees' knowledge of DKA management immediately after (primary outcome) using the simulation and 3 and 6 months post-intervention (secondary outcome); 2) Determine whether a preselected number of DKA simulator practice cases or a self-selected number (self-regulated learning) of DKA simulator practice cases will result in superior trainee knowledge with respect to DKA management immediately after (primary outcome) and 3 and 6 months post-intervention (secondary outcome).
| Status | Completed |
| Enrollment | 124 |
| Est. completion date | October 2015 |
| Est. primary completion date | June 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: First-year internal Medicine trainees (PGY-1) in their first 6 months of training and third-year medical students (CC3) were recruited to participate in this study. Inclusion criteria were: either a CC3 or PGY-1 rotating through their General Internal Medicine (GIM) rotation at one of the 7 teaching sites in Toronto. Exclusion Criteria: Excluded were those participants who participated in the DKA study during a previous block and participants who were not rotating through a GIM rotation. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| St. Michael's Hospital, Toronto |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Test 1 scores | Difference in simulator scores between the 4 cohorts immediately post- intervention (Test 1) | Immediately after intervention | No |
| Secondary | Test 2 and Test 3 scores | Difference in simulator scores between the four cohorts 3 and 6 months post- intervention (Tests 2 and 3). | 3 and 6 months after intervention | No |
| Secondary | Self-reported comfort with DKA management (5-point Likert scale) | Differences in comfort level with DKA management between the 4 cohorts after the intervention and throughout the study. | Before, immediately after, 3 months after intervention | No |
| Secondary | Correlation between simulator score and standardized exam score | CC3 participant scores on their standardized DKA-specific Objective Standardized Clinical Exam (OSCE) stations and DKA-specific written examination questions, as well as PGY-1 scores on their standardized DKA-specific OSCE stations were obtained and compared with their scores on Test 1 (primary outcome) | Immediately after intervention, end of rotation (up to 10 months after intervention) | No |
| Secondary | Number of simulations conducted | The average number of simulations per cohort were compared throughout the study. | From intervention to 6 months after intervention | No |
| Secondary | Scores on Standardized exams | Scores on the PGY-1 and CC3 standardized exams were compared in each cohort. | End of rotation (up to 10 months after intervention) | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
| Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
| Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
| Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
| Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
| Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
| Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
| Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
| Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
| Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
| Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
| Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
| Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |